Oncimmune Holdings plc (LON:ONC – Get Free Report)’s share price passed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of GBX 14.40 ($0.18) and traded as low as GBX 11.80 ($0.15). Oncimmune shares last traded at GBX 11.80 ($0.15), with a volume of 98,621 shares traded.
Oncimmune Trading Down 5.6 %
The company has a market capitalization of £8.75 million, a PE ratio of -393.33 and a beta of 1.19. The stock’s fifty day moving average price is GBX 14.40 and its two-hundred day moving average price is GBX 14.80. The company has a quick ratio of 0.63, a current ratio of 1.13 and a debt-to-equity ratio of 806.85.
Oncimmune Company Profile
Oncimmune Holdings plc, an immunodiagnostics company, develops solutions for immuno-oncology, autoimmune disease and infectious diseases in the United Kingdom, North America, Europe, and internationally. It offers EarlyCDT-Lung, an immunodiagnostic blood test for detecting and identifying lung cancer; ImmunoINSIGHTS that enables life science organizations to optimize drug development and delivery; SeroTag discovery arrays for discovering and validating biomarkers for stratifying patients in multiple cancer indications, infectious diseases, and with various autoimmune diseases; and NavigAID, a disease-specific characterization panel.
Read More
- Five stocks we like better than Oncimmune
- CD Calculator: Certificate of Deposit Calculator
- MP Materials: Rare Earth Elements Powering the EV Boom
- Business Services Stocks Investing
- Verizon’s Turnaround Gains Traction: New Highs Are Likely in 2025
- Quiet Period Expirations Explained
- Bloom Energy: Powering the Future With Decentralized Energy
Receive News & Ratings for Oncimmune Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncimmune and related companies with MarketBeat.com's FREE daily email newsletter.